Find Lip Clinical Trials in Boston, Massachusetts – 20 Enrolling Now

Showing 1–20 of 20 trials

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Head and Neck Squamous Cell Carcinoma+22 more

National Cancer Institute (NCI)150 enrolled221 locationsNCT05136196

Recruiting

Phase 3

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

Metastatic Dedifferentiated LiposarcomaStage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8+3 more

National Cancer Institute (NCI)365 enrolled250 locationsNCT06422806

Recruiting

Phase 3

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Metastatic Head and Neck Squamous Cell CarcinomaStage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8Recurrent Head and Neck Squamous Cell Carcinoma+18 more

National Cancer Institute (NCI)158 enrolled177 locationsNCT06589804

Recruiting

Phase 3

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Cardiovascular Disease and Lipoprotein(a)

Novartis Pharmaceuticals5,700 enrolled492 locationsNCT07517263

Recruiting

Phase 2

A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation

PIK3CA MutationVascular MalformationsPIK3CA-Related Overgrowth Spectrum (PROS)+4 more

Relay Therapeutics, Inc.277 enrolled31 locationsNCT06789913

Recruiting

Phase 2

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Head and Neck Squamous Cell CarcinomaStage III Hypopharyngeal Carcinoma AJCC v8Stage III Laryngeal Cancer AJCC v8+13 more

ECOG-ACRIN Cancer Research Group189 enrolled640 locationsNCT02734537

Recruiting

Phase 2Phase 3

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Tongue Squamous Cell CarcinomaOral Cavity Squamous Cell CarcinomaStage I Lip and Oral Cavity Cancer AJCC v8+9 more

NRG Oncology686 enrolled106 locationsNCT04333537

Recruiting

Phase 2

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Head and Neck Squamous Cell CarcinomaStage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+38 more

NRG Oncology98 enrolled149 locationsNCT06532279

Recruiting

Lymphatic Anomalies Registry for the Assessment of Outcome Data

Lymphatic MalformationCLOVES SyndromeKlippel Trenaunay Syndrome+7 more

Boston Children's Hospital1,000 enrolled1 locationNCT02399527

Recruiting

Phase 1Phase 2

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

AngiosarcomaLiposarcomaAdipocytic Neoplasm+6 more

St. Jude Children's Research Hospital139 enrolled6 locationsNCT06239272

Recruiting

International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

Gaucher DiseaseCerebroside Lipidosis SyndromeGlucocerebrosidase Deficiency Disease+1 more

Genzyme, a Sanofi Company12,000 enrolled318 locationsNCT00358943

Recruiting

Phase 1

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

Metastatic SarcomaMetastatic LeiomyosarcomaUnresectable Leiomyosarcoma+9 more

National Cancer Institute (NCI)30 enrolled16 locationsNCT05711615

Recruiting

Phase 3

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

LeiomyosarcomaRetroperitoneal SarcomaLiposarcoma

European Organisation for Research and Treatment of Cancer - EORTC250 enrolled164 locationsNCT04031677

Recruiting

Lysosomal Acid Lipase (LAL) Deficiency Registry

Lysosomal Acid Lipase DeficiencyWolman DiseaseCholesterol Ester Storage Disease+4 more

Alexion Pharmaceuticals, Inc.300 enrolled104 locationsNCT01633489

Recruiting

Phase 3

Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

Familial Partial Lipodystrophy

Amryt Pharma24 enrolled7 locationsNCT06679270

Recruiting

Phase 1

BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma

LiposarcomaMyxoid LiposarcomaRecurrent Liposarcoma+4 more

Michael Wagner, MD24 enrolled2 locationsNCT06414434

Recruiting

Not Applicable

Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy

DyslipidemiasPeripheral Vascular DiseasesPeripheral Artery Disease

Brigham and Women's Hospital400 enrolled1 locationNCT06300450

Recruiting

Mucolipidosis Type IV Natural History Study

Mucolipidosis Type IV

Massachusetts General Hospital50 enrolled1 locationNCT05782387

Recruiting

Identification of Biomarkers for Patients with Vascular Anomalies

Vascular AnomalyKlippel Trenaunay SyndromeKaposiform Hemangioendothelioma+4 more

Children's Hospital Medical Center, Cincinnati1,000 enrolled2 locationsNCT03001180

Lip Clinical Trials in Boston, Massachusetts

Pediatric Long-Term Follow-up and Rollover Study

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Lymphatic Anomalies Registry for the Assessment of Outcome Data

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

Lysosomal Acid Lipase (LAL) Deficiency Registry

Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma

Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy

Mucolipidosis Type IV Natural History Study

Identification of Biomarkers for Patients with Vascular Anomalies